Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 35 Breast Neoplasms 27 Prostatic Neoplasms 22 Stomach Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 12 Neoplasms 10 Lung Neoplasms 10 Urinary Bladder Neoplasms 8 Head and Neck Neoplasms 8 Triple Negative Breast Neoplasms 7 Neoplasm Metastasis 7 Carcinoma, Squamous Cell 6 Non-Muscle Invasive Bladder Neoplasms 5 Nasopharyngeal Carcinoma 5 Carcinoma, Transitional Cell 5 Adenocarcinoma 5 Oropharyngeal Neoplasms 4 Sarcoma 3 Prostatic Neoplasms, Castration-Resistant 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Ovarian Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 HER2-positive Breast Cancer 3 Esophageal Squamous Cell Carcinoma 3 Endometrial Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Vaccinia 2 Recurrence 2 Peritoneal Neoplasms 2 Metastatic Castration-Resistant Prostate Cancer 2

Interventions

Paclitaxel 1 Docetaxel 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Chemotherapy-induced Peripheral Neuropathy × Docetaxel × Clear all

NCT06491082 2024-07-08

CIN

Swami Rama Himalayan University

Chemotherapy-induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡